Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rinta-Kokko, Hanna
89  Ergebnisse:
Personensuche X
?
1

Estimating excess mortality and economic burden of Clostrid..:

Ghosh, Subrata ; Antunes, Ana ; Rinta-Kokko, Hanna...
International Journal of Infectious Diseases.  142 (2024)  - p. 106967 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Estimating excess mortality and economic burden of Clostrid..:

Antunes, Ana ; Tricotel, Aurore ; Wilk, Adrian...
BMC Infectious Diseases.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Clostridioides difficile infections, recurrences, and clini..:

Ghosh, Subrata ; Antunes, Ana ; Rinta-Kokko, Hanna...
International Journal of Infectious Diseases.  140 (2024)  - p. 31-38 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Epidemiological and clinical burden of Clostridioides diffi..:

Tricotel, Aurore ; Antunes, Ana ; Wilk, Adrian...
BMC Infectious Diseases.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

Evaluation of the indirect impact of the 10-valent pneumoco..:

Rinta-Kokko, Hanna ; Palmu, Arto A. ; Ruokokoski, Esa...
PLOS ONE.  17 (2022)  1 - p. e0261750 , 2022
Link: https://doi.org/10.1371/..
 
?
6

Effectiveness of 10 and 13-valent pneumococcal conjugate va..:

Savulescu, Camelia ; Krizova, Pavla ; Valentiner-Branth, Palle...
Vaccine.  40 (2022)  29 - p. 3963-3974 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Long-term population impact of infant 10-valent pneumococca..:

Nuorti, J. Pekka ; Rinta-Kokko, Hanna ; Toropainen, Maija...
Vaccine.  40 (2022)  41 - p. 5950-5958 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Serotype Replacement after Introduction of 10-Valent and 13..:

Hanquet, Germaine ; Krizova, Pavla ; Dalby, Tina...
Emerging Infectious Diseases.  28 (2022)  1 - p. 137-138 , 2022
Link: https://doi.org/10.3201/..
 
?
9

Long-term population effects of infant 10-valent pneumococc..:

Polkowska, Aleksandra ; Rinta-Kokko, Hanna ; Toropainen, Maija..
Vaccine.  39 (2021)  23 - p. 3216-3224 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Effectiveness of 10-valent pneumococcal conjugate vaccine e..:

Rinta-Kokko, Hanna ; Auranen, Kari ; Toropainen, Maija...
Vaccine.  38 (2020)  6 - p. 1559-1564 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Impact and effectiveness of a conjugate vaccine against inv..:

Rinta-Kokko, Hanna ; Nurhonen, Markku ; Auranen, Kari
Human Vaccines & Immunotherapeutics.  17 (2020)  6 - p. 1834-1843 , 2020
Link: https://doi.org/10.1080/..
 
?
12

Vaccine-preventable disease incidence of pneumococcal conju..:

Palmu, Arto A. ; Jokinen, Jukka ; Nieminen, Heta...
Vaccine.  36 (2018)  14 - p. 1816-1822 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Long-term impact of 10-valent pneumococcal conjugate vaccin..:

Rinta-Kokko, Hanna ; Palmu, Arto A. ; Auranen, Kari...
Vaccine.  36 (2018)  15 - p. 1934-1940 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Impact of ten-valent pneumococcal conjugate vaccine on pneu..:

Palmu, Arto A. ; Rinta-Kokko, Hanna ; Nohynek, Hanna...
PLOS ONE.  12 (2017)  3 - p. e0172690 , 2017
Link: https://doi.org/10.1371/..
 
?
15

Impact of Ten-Valent Pneumococcal Conjugate Vaccination on ..:

Jokinen, Jukka ; Rinta-Kokko, Hanna ; Siira, Lotta...
PLOS ONE.  10 (2015)  3 - p. e0120290 , 2015
Link: https://doi.org/10.1371/..
 
1-15